Reaktion #305

ord-80551a125bb34e24a0d215f47bcdf5d9

Reaktionsgleichung

COc1cc(Br)ccc1OCc1ccccc1
COc1cc(Br)ccc1OCc1cc
C[C@@H]1CNCCN1C(=O)OC(C)(C)C
C[C@@H]1CNCCN1C(=O)O
COc1cc(N2CCN[C@H](C)C2)ccc1OCc1ccccc1
COc1cc(N2CCN[C@H](C)
Ausbeute 40.3%

Lösungsmittel

Reaktionsbedingungen

Temperatur
80°CELSIUS

Vorschrift

To (R)-tert-butyl 2-methylpiperazine-1-carboxylate (0.717 g, 3.58 mmol), TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (0.094 g, 0.10 mmol) and 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (0.085 g, 0.14 mmol) and Sodium tert-butoxide (0.459 g, 4.78 mmol) was added a solution of 1-(benzyloxy)-4-bromo-2-methoxybenzene (1 g, 3.41 mmol) in Toluene (25 mL). The reaction was heated to 80 °C for 18 hours. the reaction was allowed to cool to room temperature and diluted with dcm (50 ml). This was washed with water (2 x 50 ml), dried over sodium sulfate, filtered and the solvent removed under reduced pressure. The crude product was dissolved in hydrochloric acid solution in methanol (4N, 20 ml) and stirred at room temprature overnight. The solvent was removed under reduced pressure.The crude product was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and pure fractions were evaporated to dryness to afford (R)-1-(4-(benzyloxy)-3-methoxyphenyl)-3-methylpiperazine (0.429 g, 40.3 %) as a yellow gum.

Quelle

750 AstraZeneca ELN dataset